home / stock / dmac / dmac short
Short Information | DiaMedica Therapeutics Inc. (NASDAQ:DMAC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 107,327 |
Total Actual Volume | 705,276 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 1 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 5,366 |
Average Short Percentage | 19.86% |
Is there a DMAC Short Squeeze or Breakout about to happen?
See the DMAC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-30-2024 | $2.5926 | $2.53 | $2.5926 | $2.52 | 7,605 | 4 | 0.05% |
04-29-2024 | $2.57 | $2.59 | $2.6 | $2.5399 | 8,793 | 3,541 | 40.27% |
04-26-2024 | $2.51 | $2.57 | $2.59 | $2.4943 | 7,764 | 517 | 6.66% |
04-25-2024 | $2.49 | $2.53 | $2.55 | $2.49 | 7,052 | 1,086 | 15.4% |
04-24-2024 | $2.54 | $2.45 | $2.54 | $2.4 | 7,871 | 1,436 | 18.24% |
04-23-2024 | $2.5599 | $2.42 | $2.5599 | $2.4131 | 5,228 | 880 | 16.83% |
04-22-2024 | $2.36 | $2.51 | $2.56 | $2.26 | 21,158 | 8,366 | 39.54% |
04-19-2024 | $2.49 | $2.39 | $2.5412 | $2.37 | 21,009 | 746 | 3.55% |
04-18-2024 | $2.545 | $2.49 | $2.61 | $2.45 | 17,421 | 5,803 | 33.31% |
04-17-2024 | $2.39 | $2.6 | $2.635 | $2.39 | 40,806 | 8,519 | 20.88% |
04-16-2024 | $2.36 | $2.37 | $2.41 | $2.2906 | 16,028 | 3,711 | 23.15% |
04-15-2024 | $2.36 | $2.39 | $2.4161 | $2.29 | 28,638 | 3,456 | 12.07% |
04-12-2024 | $2.54 | $2.43 | $2.57 | $2.4101 | 57,793 | 3,140 | 5.43% |
04-11-2024 | $2.67 | $2.54 | $2.67 | $2.4 | 38,925 | 8,586 | 22.06% |
04-10-2024 | $2.7 | $2.65 | $2.82 | $2.65 | 188,112 | 10,233 | 5.44% |
04-09-2024 | $2.79 | $2.71 | $2.79 | $2.71 | 20,712 | 7,385 | 35.66% |
04-08-2024 | $2.9 | $2.78 | $2.9 | $2.77 | 20,587 | 1,502 | 7.3% |
04-05-2024 | $2.95 | $2.98 | $3.2 | $2.87 | 118,472 | 15,788 | 13.33% |
04-04-2024 | $2.82 | $2.95 | $2.95 | $2.7 | 45,577 | 5,872 | 12.88% |
04-03-2024 | $2.73 | $2.8 | $2.82 | $2.7 | 25,725 | 16,756 | 65.14% |
News, Short Squeeze, Breakout and More Instantly...
DiaMedica Therapeutics Inc. Company Name:
DMAC Stock Symbol:
NASDAQ Market:
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today announced the first patient being dosed in DiaMedica’s relaunch of its pivotal Phase 2/3 ReMEDy2 Trial of...
Conference Call and Webcast March 20 at 8:00 AM Eastern Time / 7:00 AM Central Time ReMEDy2 Clinical Site Activation Commenced in December 2023 Strengthened Management Team with Lorianne Masuoka, M.D., as Chief Medical Officer $53 Million Cash with Runway to 2026 ...
DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developi...